William Beaumont Hospital, Royal Oak
Welcome,         Profile    Billing    Logout  
 2 Trials 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Haines, David E
RESOLVE-AF, NCT05883631: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy.

Recruiting
N/A
400
Europe, US, RoW
Electrographic Flow (EGF) mapping and ablation of EGF-identified sources of Atrial Fibrillation, OptiMap™ System, Electrographic Flow (EGF) mapping (no ablation)
Cortex, Ablacon, Inc.
Atrial Fibrillation, Atrial Fibrillation, Persistent, Atrial Fibrillation Paroxysmal, Arrhythmia, Arrhythmias, Cardiac, Atrial Flutter, Atrial Fibrillation, Paroxysmal or Persistent, Atrial Arrhythmia, Atrial Tachycardia
03/25
03/25
Swor, Robert
ICECAP, NCT04217551: Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients

Recruiting
N/A
1800
US
Therapeutic Hypothermia
University of Michigan, Johns Hopkins University, Medical University of South Carolina, National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS)
Cardiac Arrest, Out-Of-Hospital, Hypothermia, Induced, Hypoxia-Ischemia, Brain
07/28
08/28

Download Options